Clinical Trial Update: MEASuRE: Metreleptin Effectiveness And Safety Registry

View source ↗

Summary

MEASuRE is a registry studying the effectiveness and safety of metreleptin for generalized lipodystrophy and partial lipodystrophy. The study is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Lipodystrophy
• Partial Lipodystrophy

Drugs mentioned

• Myalepta (metreleptin)

Snippet

Sponsor: Amryt Pharma | Conditions: Generalised Lipodystrophy, Partial Lipodystrophy | Status: RECRUITING